Application of L-arabinopyranose in preparing medicines for treating telotism dysfunction

A technology for erectile dysfunction and arabinose, which is applied in the field of preparation of drugs for the treatment of erectile dysfunction, can solve problems such as limited market prospects, high price, and difficulty in obtaining, achieves improvement of erectile dysfunction in men, avoids bad taste, and avoids potential damage effect

Active Publication Date: 2011-09-21
SHENGQUAN HEALTANG CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But ginseng with good curative effect has a long growth cycle, high price and is not easy to obtain, thus limiting the market prospect of the composition
At the same time, because both are medicines, they cannot be directly used as food, so they cannot be fully applied to the needs of different patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] In the examples of the present invention, all raw materials involved are commercially available food-grade products. In the following experiments, experiments were conducted by directly adding L-arabinose to the diet of experimental mice.

[0014] A total of 39 3-month-old male SD rats of SPF grade were selected, weighing 203±31g. Rats were purchased from the Institute of Experimental Animals, Chinese Academy of Medical Sciences, fed with full-price feed during the maintenance period, free to eat and drink, room temperature 25°C±3°C, humidity 55%±15%, and natural light.

[0015] The 39 rats were randomly divided into 3 groups: 15 rats in the normal control group A, 12 rats in each of the model group B and the L-arabinose group C.

[0016] Modeling method: D-galactose is currently recognized as an aging substance, which can cause testicular damage in rats, and can be used to make a subacute aging rat model.

[0017] Normal control group A rats were subcutaneously injec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of L-arabinopyranose in preparing medicines for treating telotism dysfunction. The medicines can improve the male telotism dysfunction.

Description

technical field [0001] The present invention relates to the use of L-arabinose, in particular to the use of L-arabinose in the preparation of medicines for treating penile erectile dysfunction. Background technique [0002] L-Arabinose, also known as L(+)-Arabinose, L(+)-Apentose, Pectin Sugar, etc., was originally obtained from a colloid secreted by the Arabic tree through complex chemical and physical processes. The method separates and extracts a kind of monosaccharide, hence the name. The traditional use of L-arabinose is as a sweetener. In recent years, scientists and nutritionists have found that L-arabinose can selectively inhibit the activity of sucrose hydrolase in the small intestine and block the normal metabolism of sucrose in the human body, thereby avoiding the blood sugar in the human body after excessive intake of sucrose The abnormal increase of the value can further prevent obesity and other diseases caused by hyperglycemia (see the Chinese patent documen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7004A61P15/10A23L1/30A23L33/125
Inventor 唐一林江成真丁继程邱泼
Owner SHENGQUAN HEALTANG CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap